Form 4: Cardlytics Director Scott A. Hill Acquires Shares
Statement of Changes in Beneficial Ownership
Cardlytics, Inc. Director Scott A. Hill reported the acquisition of 11,000 shares of common stock through the vesting of restricted stock units.
Summary
- Scott A. Hill, a Director at Cardlytics, Inc., acquired 11,000 shares of common stock.
- The acquisition occurred on May 20, 2026, and was a result of restricted stock units (RSUs) vesting.
- These RSUs represented a contingent right to receive one share of common stock or its cash equivalent.
- The RSUs vested in full on the one-year anniversary of their grant date, provided Mr. Hill remained a director.
- Following this transaction, Mr. Hill beneficially owns 68,748 shares of common stock directly.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents a director fulfilling equity incentive plans, indicating continued engagement and potential confidence, but it is not a new purchase with personal funds.
Positives
- Director Scott A. Hill's acquisition of shares indicates continued commitment and confidence in the company.
- The vesting of restricted stock units suggests that performance or tenure-based incentives are being met.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.
Industry Context
StockSavvy.ai notes that insider stock acquisitions, particularly by directors, are often viewed positively by the market as they can signal confidence in the company's future prospects. This transaction by a director of Cardlytics, Inc. falls within typical insider reporting activities.
Stakeholder Impact
- Shareholders may view this as a positive signal of director commitment, though it is an equity incentive vesting rather than an open market purchase.
- Employees may see this as a sign of internal confidence in the company's direction.
- Creditors and suppliers are unlikely to be directly impacted by this specific transaction.
Key Dates
| Date | Description |
|---|---|
| 05/20/2026 | Transaction Date for acquisition of common stock and vesting of RSUs. |
| 05/21/2026 | Date of filing for the Form 4 statement. |
Keywords
Cardlytics, CDLX, Form 4, Insider Trading, Stock Acquisition, Restricted Stock Units, Director, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.